Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.

Better Buy: Celgene vs. Gilead Sciences

TheMotleyFool

0 0

Should you go with the biotech that's going away or the one that's bouncing back? That's pretty much the question for investors when it comes to deciding between Celgene (NASDAQ: CELG) and Gilead Sciences (NASDAQ: GILD).

Celgene is probably only a few months away from being absorbed by Bristol-Myers Squibb (NYSE: BMY). Gilead appears to be making a comeback after several years of revenue and earnings declines. Which stock is now the better pick for investors?

Image source: Getty Images.

Source Fool.com

Like: 0

GILD

Share